MAPS Americas Annual Meeting 2024
Find us at Booth #415 to discuss how we can help you chart a new Medical Affairs path toward a more patient-centric drug and device development pipeline.
March 24-27, 2024
The biopharma and MedTech industries are experiencing unprecedented change, moving toward a more patient-centric approach to drug and device development.
Medical affairs teams play a crucial role in bridging the gap between research and development (R&D) teams and commercial teams, incorporating patient insights throughout the drug development continuum.
Driven by real-world evidence (RWE), omnichannel engagement and generative AI technologies, Syneos Health Medical Affairs is innovating to drive strategic medical transformation and help companies chart a new path toward a more patient-centric drug and development pipeline.
Find us at booth #415 or schedule a meeting to learn how you can super-charge Medical Affairs to amplify your science to communicate value and improve patient care.
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Medical Affairs at Syneos Health
Syneos Health Medical Science Liaisons
Engaging Patient Communities: The Changing Role of Medical Affairs
Effective Patient Community Engagement: Guidelines for Medical Affairs Teams
It’s Time We Got the Most Out of Medical Affairs Data